BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, November 27, 2024
See today's BioWorld MedTech
Home
» Oxford Nanopore raises £80M in fundraise with £50M from Novo Holdings
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Oxford Nanopore raises £80M in fundraise with £50M from Novo Holdings
Aug. 1, 2024
By
Shani Alexander
No Comments
Oxford Nanopore Technologies plc secured £80 million (US$102 million) in an oversubscribed equity raise, with £50 million coming from Novo Holdings.
BioWorld MedTech
Financings
Europe
